213 related articles for article (PubMed ID: 21069389)
1. Serum cystatin C for estimation of residual renal function in children on peritoneal dialysis.
Kim SJ; Sohn YB; Park SW; Jin DK; Paik KH
Pediatr Nephrol; 2011 Mar; 26(3):433-40. PubMed ID: 21069389
[TBL] [Abstract][Full Text] [Related]
2. Residual renal function assessment with cystatin C.
Filler G; Huang SH; Lindsay RM
Pediatr Nephrol; 2011 Mar; 26(3):333-5. PubMed ID: 21058022
[TBL] [Abstract][Full Text] [Related]
3. Relationship of serum cystatin C to peritoneal and renal clearance measures in peritoneal dialysis: a cross-sectional study.
Delaney MP; Stevens PE; Al Hasani M; Stowe HJ; Judge C; Lamb EJ
Am J Kidney Dis; 2008 Feb; 51(2):278-84. PubMed ID: 18215705
[TBL] [Abstract][Full Text] [Related]
4. Is cystatin C a better marker than creatinine for evaluating residual renal function in patients on continuous ambulatory peritoneal dialysis?
Yang Q; Li R; Zhong Z; Mao H; Fan J; Lin J; Yang X; Wang X; Li Z; Yu X
Nephrol Dial Transplant; 2011 Oct; 26(10):3358-65. PubMed ID: 21367849
[TBL] [Abstract][Full Text] [Related]
5. Influence of residual renal function on dietary protein and caloric intake in patients on incremental peritoneal dialysis.
Caravaca F; Arrobas M; Dominguez C
Perit Dial Int; 1999; 19(4):350-6. PubMed ID: 10507816
[TBL] [Abstract][Full Text] [Related]
6. Serum Cystatin C Does Not Predict Mortality or Treatment Failure in Peritoneal Dialysis: A Prospective Study.
Delaney MP; Stevens PE; Witham HJ; Judge C; Eaglestone GL; Carter JL; Bassett P; Lamb EJ
Perit Dial Int; 2016; 36(1):94-100. PubMed ID: 25185011
[TBL] [Abstract][Full Text] [Related]
7. C-terminal agrin fragment (CAF) as a serum biomarker for residual renal function in peritoneal dialysis patients.
Steubl D; Hettwer S; Dahinden P; Luppa P; Rondak IC; Regenbogen C; Stock KF; Renders L; Heemann U; Roos M
Int Urol Nephrol; 2015 Feb; 47(2):391-6. PubMed ID: 25352149
[TBL] [Abstract][Full Text] [Related]
8. Residual renal function in a large cohort of peritoneal dialysis patients: change over time, impact on mortality and nutrition.
Shemin D; Bostom AG; Lambert C; Hill C; Kitsen J; Kliger AS
Perit Dial Int; 2000; 20(4):439-44. PubMed ID: 11007376
[TBL] [Abstract][Full Text] [Related]
9. Relationship between residual renal function and serum fibroblast growth factor 23 in patients on peritoneal dialysis.
Yamada S; Tsuruya K; Taniguchi M; Yoshida H; Tokumoto M; Hasegawa S; Tanaka S; Eriguchi M; Nakano T; Kitazono T
Ther Apher Dial; 2014 Oct; 18(5):383-90. PubMed ID: 24674095
[TBL] [Abstract][Full Text] [Related]
10. Estimation of residual glomerular filtration rate and renal Kt/Vurea from creatinine clearance in end-stage renal disease patients. The Netherlands Cooperative Study on the Adequacy of Dialysis.
Korevaar JC; Jansen MA; Dekker FW; Boeschoten EW; Krediet RT
Adv Perit Dial; 1999; 15():132-7. PubMed ID: 10682088
[TBL] [Abstract][Full Text] [Related]
11. KP index at the initiation of dialysis for patients with end-stage renal disease.
Hwang EW; Ji SB; Kim JK; Hwang SD
Korean J Intern Med; 2004 Jun; 19(2):81-6. PubMed ID: 15366637
[TBL] [Abstract][Full Text] [Related]
12. Urea kinetic analysis of automated peritoneal dialysis allows calculation of a CAPD-equivalent Kt/V(urea).
Schurman SJ; Shoemaker LR; Warady BA
Kidney Int; 2000 Sep; 58(3):1318-24. PubMed ID: 10972696
[TBL] [Abstract][Full Text] [Related]
13. Relationship between dialysis adequacy and quality of life in long-term peritoneal dialysis patients.
Chen YC; Hung KY; Kao TW; Tsai TJ; Chen WY
Perit Dial Int; 2000; 20(5):534-40. PubMed ID: 11117244
[TBL] [Abstract][Full Text] [Related]
14. The outcome for pediatric patients on peritoneal dialysis.
Acar B; Yalcinkaya F; Cakar N; Yüksel S; Ozçakar ZB; Uncu N; Kara N; Elhan AH; Ekim M
J Nephrol; 2008; 21(3):394-9. PubMed ID: 18587728
[TBL] [Abstract][Full Text] [Related]
15. Toward targets for initiation of chronic dialysis.
Mehrotra R; Saran R; Moore HL; Prowant BF; Khanna R; Twardowski ZJ; Nolph KD
Perit Dial Int; 1997; 17(5):497-508. PubMed ID: 9358533
[TBL] [Abstract][Full Text] [Related]
16. The association between serum cystatin C and residual renal function in peritoneal dialysis patients.
Zhang S; Li H; Cai X; Zhao C; Cao J
Ther Apher Dial; 2022 Dec; 26(6):1241-1246. PubMed ID: 35253373
[TBL] [Abstract][Full Text] [Related]
17. A simple method to evaluate residual renal function by spot urinary cystatin C-to-creatinine ratio in peritoneal dialysis patients.
Adachi Y; Nishio A
Perit Dial Int; 2010; 30(4):464-7. PubMed ID: 20628107
[TBL] [Abstract][Full Text] [Related]
18. Is growth a valid outcome measure of dialysis clearance in children undergoing peritoneal dialysis?
Chadha V; Blowey DL; Warady BA
Perit Dial Int; 2001; 21 Suppl 3():S179-84. PubMed ID: 11887816
[TBL] [Abstract][Full Text] [Related]
19. Estimation of residual glomerular filtration rate in peritoneal dialysis patients using cystatin C: comparison with 51Cr-EDTA clearance.
Carter JL; Lane CE; Fan SL; Lamb EJ
Nephrol Dial Transplant; 2011 Nov; 26(11):3729-32. PubMed ID: 21441400
[TBL] [Abstract][Full Text] [Related]
20. Association between residual renal function, inflammation and patient survival in new peritoneal dialysis patients.
Chung SH; Heimbürger O; Stenvinkel P; Qureshi AR; Lindholm B
Nephrol Dial Transplant; 2003 Mar; 18(3):590-7. PubMed ID: 12584284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
